pharmaceutical investing Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse
pharmaceutical investing Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results
pharmaceutical investing Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse
Syntholene Engages Imperial College of London Expert for Independent Technical Review of Operating Data from Iceland Demonstration Facility
QIMC Ties New Salem-Apple River Helium Zones to a Buried Basement Structure: Gravity, Magnetics and Geochemistry Converge on a Single Fault-Bounded Ramp
